PACDB provides the information on pathogens (e.g. bacteria, fungus, toxin and virus) adhering to carbohydrates expressed on the cell surface of host animals or plants.
Database | Last Updated |
---|---|
Pathogen Adherence to Carbohydrate Database (PACDB) | June 1, 2016 |
Species | Pathogen Adherence Molecule | Ligand Name | Ligand Feature | Target Source | Glycan Sequence | Binding ▲ | PubMed ID |
---|---|---|---|---|---|---|---|
Cholera toxin
|
Gb4 (Globoside; Globotetraose; P antigen)
|
Oligoglycosylceramides
|
GalNAc(b1-3)Gal(a1-4)Gal(b1-4)Glc(b1-1)Cer
|
Not Binding
|
|||
Cholera toxin
|
Lc4Cer (Lactotetraosylceramide)
|
Oligoglycosylceramides
|
Gal(b1-3)GlcNAc(b1-3)Gal(b1-4)Glc(b1-1)Cer
|
Not Binding
|
|||
Shiga toxin
|
isoGb3 (Isoglobotriaosylceramide; iGb3)
|
Oligoglycosylceramides
|
Gal(a1-3)Gal(b1-4)Glc(b1-1)Cer
|
Not Binding
|
|||
Shiga toxin
|
unnamed ligand
|
Oligoglycosylceramides
|
GalNAc(a1-3)[Fuc(a1-2)]Gal(b1-3)GalNAc(b1-3)Gal(a1-4)Gal(b1-4)Glc(b1-1)Cer
|
Not Binding
|
|||
Shiga toxin
|
Gb5 (Forssman glycolipid)
|
Oligoglycosylceramides
|
GalNAc(a1-3)GalNAc(b1-3)Gal(a1-4)Gal(b1-4)Glc(b1-1)Cer
|
Not Binding
|
|||
Heat-labile enterotoxin
|
H5 type 2 pentaglycosylceramide (neolacto-series)
|
Oligoglycosylceramides
|
Fuc(a1-2)Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)Glc(b1-1)Cer
|
Not Binding
|
|||
Heat-labile enterotoxin
|
Asialo-GM2 (Gangliotriosylceramide; GgO3)
|
Oligoglycosylceramides
|
GalNAc(b1-4)Gal(b1-4)Glc(b1-1)Cer
|
Not Binding
|
|||
Heat-labile enterotoxin
|
Gb4 (Globoside; Globotetraose; P antigen)
|
Oligoglycosylceramides
|
GalNAc(b1-3)Gal(a1-4)Gal(b1-4)Glc(b1-1)Cer
|
Not Binding
|
|||
Heat-labile enterotoxin
|
Lc4Cer (Lactotetraosylceramide)
|
Oligoglycosylceramides
|
Gal(b1-3)GlcNAc(b1-3)Gal(b1-4)Glc(b1-1)Cer
|
Not Binding
|
|||
Unknown
|
H5 type 2 pentaglycosylceramide (neolacto-series)
|
Oligoglycosylceramides
|
Fuc(a1-2)Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)Glc(b1-1)Cer
|
Not Binding
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01